Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Aimmune secures licence to Xencor’s XmA 7195 to develop food allergy treatments
Aimmune has secured exclusive licence to Xencor’s XmA 7195 for the development of food allergy treatments (Credit: Deborah Breen Whiting from Pixabay)
Aimmune has secured exclusive licence to Xencor’s XmA 7195 for the development of food allergy treatments (Credit: Deborah Breen Whiting from Pixabay)